[Evaluation of the performance of regionalization of health surveillance in six Brazilian Health Regions].

Cad Saude Publica

Grupo de Estudos de Gestão e Avaliação em Saúde, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brasil.

Published: August 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study aimed to assess the performance of health surveillance regionalization with different levels of development in Brazil. A cross-sectional quantitative approach was used with data collected through a structured questionnaire, prepared on the basis of three study dimensions (Policy, Structure, and Organization), applied to 31 key actors in health surveillance in the selected Health Regions and municipalities. The measure of central tendency was mean score, and synthetic indices were obtained for each dimension and attribute. Three cutoff points were assigned to assess performance: values less than or equal to 4.99 were considered unsatisfactory; from 5.00 to 6.99, intermediate; and greater than or equal to 7.00, satisfactory. The study found that regionalization performance in health surveillance was only satisfactory in one region, intermediate in four, and unsatisfactory in one. Among the three dimensions, Policy and Organization showed the best performance and Structure showed the worst. In conclusion, in general, the higher the level of socioeconomic development and services supply, the better the performance in regionalization of health surveillance. The evaluation portrays the complexity of contexts in different regions of Brazil, thus contributing to understanding the dynamics of health surveillance regionalization in Brazil.

Download full-text PDF

Source
http://dx.doi.org/10.1590/0102-311X00065218DOI Listing

Publication Analysis

Top Keywords

health surveillance
24
performance regionalization
8
health
8
regionalization health
8
assess performance
8
performance health
8
surveillance regionalization
8
dimensions policy
8
surveillance
6
regionalization
5

Similar Publications

Background: Omeprazole, a widely used proton pump inhibitor, has been associated with rare but serious adverse events such as myopathy. Previous research suggests that concurrent use of omeprazole with fluconazole, a potent cytochrome P450 (CYP) 2C19/3A4 inhibitor, may increase the risk of myopathy. However, the contribution of genetic polymorphisms in CYP enzymes remains unclear.

View Article and Find Full Text PDF

Aims And Objective: The field of medical statistics has experienced significant advancements driven by integrating innovative statistical methodologies. This study aims to conduct a comprehensive analysis to explore current trends, influential research areas, and future directions in medical statistics.

Methods: This paper maps the evolution of statistical methods used in medical research based on 4,919 relevant publications retrieved from the Web of Science.

View Article and Find Full Text PDF

Purpose: Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a rare cancer susceptibility syndrome exclusively attributable to pathogenic variants in FH (HGNC:3700). This paper quantitatively weights the phenotypic context (PP4/PS4) of such very rare variants in FH.

Methods: We collated clinical diagnostic testing data on germline FH variants from 387 individuals with HLRCC and 1,780 individuals with renal cancer, and compared the frequency of 'very rare' variants in each phenotypic cohort against 562,295 population controls.

View Article and Find Full Text PDF

Background: Cerebrovascular reactivity reflects changes in cerebral blood flow in response to an acute stimulus and is reflective of the brain's ability to match blood flow to demand. Functional MRI with a breath-hold task can be used to elicit this vasoactive response, but data validity hinges on subject compliance. Determining breath-hold compliance often requires external monitoring equipment.

View Article and Find Full Text PDF

Objectives: To assess changes in greenhouse gas emission rates associated with the use of anaesthetic gases (desflurane, sevoflurane, and isoflurane) in Australian health care during 2002-2022, overall and by state or territory and hospital type.

Study Design: Retrospective descriptive analysis of IQVIA anaesthetic gases purchasing data.

Setting: All Australian public and private hospitals, 1 January 2002 - 31 December 2022.

View Article and Find Full Text PDF